This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Chain Biotechnology Limited. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Benjamin Michael Bradley
Introduction
Benjamin Michael Bradley is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of compositions for treating inflammatory diseases. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Bradley's latest patents include innovative compositions and methods aimed at treating inflammatory diseases. One of his key inventions focuses on compositions for treating conditions such as inflammatory bowel disease (IBD) and colorectal cancer. Additionally, he has developed probiotic compositions that are designed to address gastrointestinal disorders. These advancements highlight his commitment to improving health outcomes through scientific innovation.
Career Highlights
Benjamin Michael Bradley is currently associated with Chain Biotechnology Limited, where he continues to push the boundaries of research and development in biotechnology. His work is characterized by a strong focus on practical applications that can lead to better treatment options for patients suffering from various inflammatory conditions.
Collaborations
Bradley collaborates with esteemed colleagues, including Edward Green and Richard Mark Edwards. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.
Conclusion
In summary, Benjamin Michael Bradley is a dedicated inventor whose work in biotechnology is paving the way for new treatments for inflammatory diseases. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile